Molecular Diagnostics: For the Clinical Laboratorian

Molecular Diagnostics: For the Clinical Laboratorian

For the Clinical Laboratorian

R 7 783.00

Takealot ยท checked 11 days ago

View at Takealot
Average
R 8 325.84
Lowest seen
R 7 783.00
Highest seen
R 8 785.00
Last change
-R 502.00
First indexed
25 Sep 2026
Retailer
Takealot

Description

A tutorial guide to molecular diagnostic techniques that takes advantage of many new molecular technologies to include both improved traditional methods and totally new methods, some not yet in routine use. It offers molecular diagnostics for genetic disease, human cancers, infectious diseases, and identity testing.
In 1994 I coedited a book, Molecular Pathology: Ap- efforts. It should be evident that molecular pathology and proaches to Diagnosing Human Disease in the Clinical diagnostics impact almost every conceivable subspecialty Laboratory, that coined the phrase "molecular pathology" in laboratory medicine and, particularly in the case of to refer to applications of molecular biology in the tradi- pharmacogenomics, have led to the development of new tional areas of laboratory medicine. That compilation of areas of investigation. clinical molecular techniques included 11 chapters and an What is less evident is the burden placed upon the epilogue on "New Directions for the Clinical Laboratory. " laboratorians directing these efforts. Issues regarding Chapter headings included: automation, neoplasia, heri- training, certification, continuing education, and re- table diseases, and infectious diseases. bursement (just to name a few) have demanded enormous Three years later, in 1997, Bill Coleman and Greg Tson- time and effort from professional organizations and g- galis edited Molecular Diagnostics: For the Clinical ernmental agencies.
In addition, because conventional Laboratorian, which contained 18 chapters and introduced approaches cannot always be applied to molecular di- the new areas of RT-PCR and In Situ PCR, and included nostics, unique solutions for quality assurance and quality a section on gene therapy. Now, ten years after the intro- control must be developed. These challenges have eng- duction of molecular pathology, we are looking at the dered committees, subcommittees, taskforces, and second edition of Bill Coleman and Greg Tsongalis' text.

Similar products